In vitro drug susceptibility of Chlamydia sp. strain TWAR.
The in vitro susceptibilities of eight Chlamydia sp. strain TWAR isolates were tested against tetracycline, erythromycin, penicillin, ampicillin, sulfisoxazole, and a new drug, trospectomycin. The ranges of inhibitory concentrations of these antimicrobial agents, except for sulfonamide, were similar to those for Chlamydia trachomatis. Sulfisoxazole was not inhibitory at the highest nontoxic concentration tested.
Kuo
C C
CC
Department of Pathobiology, University of Washington, Seattle 98195.
Grayston
J T
JT
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002689:Chlamydia / Q000187:drug effects*; D004917:Erythromycin / Q000494:pharmacology; D006801:Humans; D010400:Penicillin G / Q000494:pharmacology; D000198:Spectinomycin / Q000031:analogs & derivatives / Q000494:pharmacology; D013444:Sulfisoxazole / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; C043267:trospectomycin; D004917:Erythromycin; D013444:Sulfisoxazole; D000667:Ampicillin; D000198:Spectinomycin; D013752:Tetracycline; D010400:Penicillin G